Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can brain zaps boost social skills in kids with autism?

NCT ID NCT06368726

Symptom relief Sponsor: Spanish Foundation for Neurometrics Development Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 11, 2026 · Updated 2 times

Summary

This study tests whether 80 sessions of a gentle brain stimulation technique called tDCS, given over 12 months, can improve attention, social skills, and language in 180 children aged 6 to 11 who have autism along with rare diseases, genetic problems, or PANDAS. The treatment is non-invasive and aims to ease symptoms, not cure the condition. Children must have had a normal pregnancy and birth, and no history of head trauma or brain infections.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1/2

Runs two stages together: safety and dose first, then whether the treatment works.

Participants

180 people

The number who actually took part.

Started

Apr 2024

Finished

Sep 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 11 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 7 and 15 years old * Diagnosis: PDD, ASD or PANDAS * Have genetic alterations with geneticist reports like: mutation, random mating between organisms, random fertilization or crossing over (or recombination) between chromatids of homologous chromosomes during meiosis. * Natural birth without caesarean or complications * Normal Pregnancy Exclusion Criteria: * Head Trauma * Brain Injuries like meningitis or encephalitis, including SaRS, Herpes or MERS infections * Epilepsy * Rare Diseases with Auto-Immune Disease * Rare diseases with Endocrinology problems * Fever or Biochemical problems in the First Blood Test (First Visit) * Vaccines Reactions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type autism spectrum disorder PANDAS perceptual disorders Social Behavior stutter disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Attention Eeg with periodic abnormalities Fluency disorder Social behavior Visual perceptual weakness

Contacts and locations

Locations

  • Bigdata4brain LLC

    Albuquerque, New Mexico, 87113, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.